Tag
Aphria Inc
- Cannabis extract market to reach US$23B by 2032: The Brainy Insights
- Tilray re‑brands therapeutic divisions as Tilray Medical
- Hexo to buy 48North Cannabis for $50M
- Aurora stock falls amid more large losses and cost cuts
- Tilray 1.0 quietly discloses first-quarter US$341M loss
- Writedowns and growing pains ahead for Tilray 2.0, analyst says
- Valens enters US CBD market with purchase of Florida firm
- Tilray reduces required shareholder vote count to 1/3 for Aphria merger
- Aphria blames slump on Covid despite steady market growth
- How Aphria is fighting for more market share: marketing VP Q&A
- Can you buy brand loyalty? Canopy thinks so
- Hexo touts Q2 earnings, eyes M&A
- Is Hexo blowing smoke on Euro entry via Zenabis deal?
- Tilray's pot sales pop ahead of Aphria merger
- Hexo to enter Europe with $265M Zenabis acquisition
- Reddit traders send pot stocks to the moon ‑‑ and back
- Tilray stock soars 40% on UK supply deal with Grow Pharma
- Tilray first company approved to sell medical cannabis in Portugal
- 'No way to compromise on quality': a conversation with Broken Coast's Kevin Anderson
- Tilray to supply medical pot in France, Aphria expands brand in Germany
- Aphria stock hits 2‑year high on record Q2 sales
- Hexo, Molson Coors launch first US CBD drinks in Colorado
- Tilray and Aphria unveil merger plan to create world's biggest weed firm
- Why the Georgia Senate runoff could reshape North America's cannabis sector
- Analyst lukewarm on Aphria's US$300M SweetWater acquisition
- Pot stock leaders to consider ahead of US election: BCMI
- Aphria shares tank on weak international sales
- Weed stock index surges 7% after Kamala Harris said Biden will decriminalize
- Village Farms buys 100% ownership of Pure Sunfarms for $80M
- Is Village Farms poised to be an industry leader?
- Aphria joins Israeli medical cannabis rush with new supply deal
- Aphria shares tumble on $99M fourth-quarter loss
- BlackNorth anti-racism initiative 'a step in the right direction'
- Aphria, Double Diamond remain tight-lipped after advocacy group shares video of alleged unsafe migrant worker living conditions
- Aphria to switch listing from NYSE to Nasdaq
- Aphria renegotiates debt, lays off marketing boss
- Aphria remains profitable amid murk of insolvency
- Green Growth CEO steps down, company closes CBD mall kiosks
- MediPharm Labs teams up with Shoppers Drug Mart
- Aphria gains EU GMP certification to ship medical cannabis within Europe
- Aphria gets $80 million secured loan at 5% interest rate
- 'We Call the Bottom:' New York Bank Sees Green Days Ahead for Canadian Pot Stocks
- Aphria Obtains Long-Awaited Cultivation Licence, Doubles Production Capacity
- Aphria First Pot Company With Second Profitable Quarter
- Vaping Illegal Cannabis Oil is Putting Americans in Hospitals
- Is Aphria Looking to Buy CannTrust's Assets?
- Aphria President Jakob Ripshtein to Resign June 7
- Why Acreage-Canopy Growth Type Deals Might Be a Rarity in the Industry
- Shoppers Drug Mart Receives License to Sell Cannabis Online